Cargando…
Efficacy of Large Use of Combined Hypofractionated Radiotherapy in a Cohort of Anti-PD-1 Monotherapy-Treated Melanoma Patients
SIMPLE SUMMARY: Melanoma patients who failed anti-PD-1 therapy have limited therapeutic options. Some studies suggested the efficacy of radiotherapy combined with anti-PD-1 monoclonal antibodies. We previously reported in small-sized studies that hypofractionated radiotherapy combined with an unmodi...
Autores principales: | Saiag, Philippe, Molinier, Rafaele, Roger, Anissa, Boru, Blandine, Otmezguine, Yves, Otz, Joelle, Valery, Charles-Ambroise, Blom, Astrid, Longvert, Christine, Beauchet, Alain, Funck-Brentano, Elisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454723/ https://www.ncbi.nlm.nih.gov/pubmed/36077606 http://dx.doi.org/10.3390/cancers14174069 |
Ejemplares similares
-
Efficacy of combined hypo-fractionated radiotherapy and anti-PD-1 monotherapy in difficult-to-treat advanced melanoma patients
por: Roger, Anissa, et al.
Publicado: (2018) -
Impact du confinement lié au COVID-19 sur le retard au diagnostic et la sévérité du mélanome
por: Molinier, Rafaele, et al.
Publicado: (2021) -
Variation of mutant allele frequency in NRAS Q61 mutated melanomas
por: Hélias-Rodzewicz, Zofia, et al.
Publicado: (2017) -
Cutaneous toxicities from targeted therapies used in oncology: Literature review of clinical presentation and management
por: Huynh Dagher, Solène, et al.
Publicado: (2021) -
Hypofractionated stereotactic body radiation therapy as monotherapy for intermediate-risk prostate cancer
por: Ju, Andrew W, et al.
Publicado: (2013)